Keyphrases
Alzheimer's Disease
100%
Estrogen
51%
Neurogenesis
44%
Mexican Americans
37%
Ischemic Stroke
36%
Aging
34%
Older Adults
31%
Mild Cognitive Impairment
29%
17-estradiol
29%
Ischemia
26%
Lower Body Negative Pressure
26%
Neuroprotection
25%
Transient Middle Cerebral Artery Occlusion (tMCAO)
23%
Rat Brain
23%
Ethanol Withdrawal
22%
Oxidative Stress
21%
Focal Cerebral Ischemia
21%
Cognitive Impairment
20%
Estrogen Receptor
19%
Heart Rate
19%
Parkinson's Disease
19%
Neuroprotective Effect
18%
Non-Hispanic White
18%
Cerebral Ischemia
18%
Aging Brain
17%
Mass Spectrometry
17%
Vascular Endothelial Growth Factor
17%
Neuroglobin
16%
Central Nervous System
16%
Hippocampus
14%
Neurodegeneration
14%
Presenilin
13%
Mean Arterial Pressure
13%
Angiogenesis
13%
Subventricular Zone
13%
Hypoxia
12%
Diabetes
12%
Thyrotropin
12%
Mitochondria
12%
GABAA Receptor (GABAAR)
12%
Prodrug
12%
Executive Function
11%
Dementia
11%
Astrocytes
11%
Brain Injury
11%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
11%
Cognitive Decline
11%
Neural Stem Cells
10%
Gene Expression
10%
Neurodegenerative Diseases
10%
Oxidative Damage
10%
Texas
10%
Protein Carbonyls
10%
Reperfusion
10%
Overexpression
10%
Ethanol
9%
Neuroprotective
9%
Bromodeoxyuridine
9%
Risk Factors
9%
Aged Rats
9%
Neuropsychological Tests
9%
Metabolism
8%
Cognitive Function
8%
Hispanic Americans
8%
Rat Model
8%
Blood Biomarkers
8%
Estradiol
8%
Neurotoxicity
8%
Presenilin 1 mutation
8%
4-hydroxynonenal (4-HNE)
8%
Tandem Mass Spectrometry
8%
Transgenic Mice
8%
Adult Brain
8%
Cognitively Normal
8%
Apoptosis
8%
Latino Elders
8%
Tyrosine Hydroxylase
8%
Cortex
8%
Electrospray Ionization Mass Spectrometry
8%
Methylene Blue
8%
Aging Effect
8%
Phosphorylation
8%
Age-related Illnesses
7%
Rodents
7%
Focal Ischemia
7%
Protective Effect
7%
RBANS
7%
Chemical Delivery System
7%
COVID-19
7%
Glutamate
7%
Aged Mice
7%
Health Disparities
7%
Carotid Baroreflex
7%
Experimental Stroke
7%
Growth Factors
7%
Type 2 Diabetes Mellitus (T2DM)
7%
Multi-ethnic
7%
Blood-brain Barrier
7%
Cerebral Blood Flow
7%
Cell Death
7%
Neuroscience
Brain Ischemia
84%
Alzheimer's Disease
81%
Cerebrovascular Accident
60%
Neurogenesis
45%
Ischemia
45%
Middle Cerebral Artery
35%
Neuroprotective Agent
31%
Diethylstilbestrol
30%
Cognitive Disorders
29%
In Vitro
28%
Neuroprotection
25%
Blood Plasma
22%
In Vivo
22%
Parkinson's Disease
21%
Alcohol Withdrawal Syndrome
20%
Receptor
20%
Mild Cognitive Impairment
20%
Estrogen Receptor
17%
Vascular Endothelial Growth Factor
16%
Oxidative Stress
16%
Neuroglobin
15%
Astrocyte
15%
Hippocampus
15%
Mitochondrion
13%
Neural Stem Cell
13%
Subventricular Zone
13%
Presenilin 1
13%
Baroreflex
13%
Gene Expression
13%
Central Nervous System
13%
Neurodegeneration
12%
Angiogenesis
12%
Messenger RNA
12%
Proteomics
11%
Promoter Region
11%
Cell Death
11%
Antioxidant
11%
Neurodegenerative Disorder
10%
Amyloid Protein
10%
Neuronal Cell Death
9%
Metabolic Pathway
9%
Prodrug
9%
Tyrosine Hydroxylase
9%
Bromodeoxyuridine
9%
Cell Signaling
8%
Staining Technique
8%
GABAA Receptor
8%
Hypovolemia
8%
Cognitive Function
8%
Kinase
7%
Carotid Sinus Pressoreceptor Reflex
7%
Gamma-Aminobutyric Acid
7%
Blood Brain Barrier
7%
Cell Proliferation
7%
Reactive Oxygen Species
7%
Western Blotting
7%
Baroreceptor
6%
Glutamic Acid
6%
Caspase 3
6%
Methylene Blue
6%
Immunohistochemistry
6%
Neurotrauma
6%
Traumatic Brain Injury
6%
Striatum
6%
Thyrotropin-Releasing Hormone
6%
Corticotropin-Releasing Hormone
6%
Dihydrolipoamide Dehydrogenase
6%
Growth Factor
6%
T Cell
6%
Cerebral Cortex
6%
Cerebellum
5%
Microglia
5%
Substantia nigra
5%
Amino Terminal Sequence
5%
Behavior (Neuroscience)
5%
DNA Damage
5%
Female Rats
5%
Cell Line
5%
Postural Control
5%
Brain-Derived Neurotrophic Factor
5%
Doublecortin
5%
Magnetic Resonance Imaging
5%
Mitochondrial Protein
5%
Mass Spectrometry
5%
Excitotoxicity
5%
AMP-activated Protein Kinase
5%
Polyacrylamide Gel Electrophoresis
5%
Mammalian Target of Rapamycin
5%
Cell Survival
5%
Amyloid Precursor Protein
5%
Cannabinoid 1 Receptor
5%